Operating Expenses Summary of Biocon Limited

Biocon Limited's latest annual operating expenses in 2023 was 40.9 Billion INR , down -38.83% from previous year.
Biocon Limited's latest quarterly operating expenses in 2024 Q2 was 21.41 Billion INR , up 160.61% from previous quarter.
Biocon Limited reported a annual operating expenses of 65.04 Billion INR in annual operating expenses 2022, up 41.68% from previous year.
Biocon Limited reported a annual operating expenses of 45.91 Billion INR in annual operating expenses 2021, up 10.49% from previous year.
Biocon Limited reported a quarterly operating expenses of 21.41 Billion INR for 2024 Q2, up 160.61% from previous quarter.
Biocon Limited reported a quarterly operating expenses of 10.03 Billion INR for 2023 Q4, down -44.38% from previous quarter.

Annual Operating Expenses Chart of Biocon Limited (2023 - 2003)

Historical Annual Operating Expenses of Biocon Limited (2023 - 2003)

Year	Operating Expenses	Operating Expenses Growth
2023	40.9 Billion INR	-38.83%
2022	65.04 Billion INR	41.68%
2021	45.91 Billion INR	10.49%
2020	41.55 Billion INR	20.42%
2019	34.5 Billion INR	23.15%
2018	28.02 Billion INR	35.36%
2017	20.7 Billion INR	13.72%
2016	18.2 Billion INR	12.84%
2015	16.13 Billion INR	12.17%
2014	14.38 Billion INR	9.82%
2013	13.09 Billion INR	32.86%
2012	9.85 Billion INR	15.65%
2011	8.52 Billion INR	371.89%
2010	-3.13 Billion INR	-163.12%
2009	4.96 Billion INR	82.68%
2008	2.71 Billion INR	63.12%
2007	1.66 Billion INR	3.94%
2006	1.6 Billion INR	89.29%
2005	847.02 Million INR	15.42%
2004	733.89 Million INR	-1.8%
2003	747.32 Million INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	9.06 Billion INR	-9.69%
2024 Q2	21.41 Billion INR	160.61%
2023 Q4	10.03 Billion INR	-44.38%
2023 FY	39.78 Billion INR	-38.83%
2023 Q1	18.61 Billion INR	-2.71%
2023 Q2	19.86 Billion INR	6.74%
2023 Q3	18.04 Billion INR	-9.18%
2022 Q3	17.31 Billion INR	21.63%
2022 Q4	19.13 Billion INR	10.5%
2022 Q1	14.36 Billion INR	22.12%
2022 Q2	14.23 Billion INR	-0.88%
2022 FY	65.04 Billion INR	41.68%
2021 Q4	11.76 Billion INR	-10.49%
2021 FY	45.91 Billion INR	10.49%
2021 Q1	10.35 Billion INR	9.18%
2021 Q2	11.21 Billion INR	8.3%
2021 Q3	13.13 Billion INR	17.21%
2020 Q1	9.62 Billion INR	21.48%
2020 Q4	9.48 Billion INR	-18.69%
2020 Q3	11.66 Billion INR	7.51%
2020 Q2	10.84 Billion INR	12.74%
2020 FY	41.55 Billion INR	20.42%
2019 Q3	9.57 Billion INR	5.8%
2019 Q2	9.05 Billion INR	13.73%
2019 FY	34.5 Billion INR	23.15%
2019 Q1	7.95 Billion INR	17.68%
2019 Q4	7.91 Billion INR	-17.31%
2018 FY	28.02 Billion INR	35.36%
2018 Q4	6.76 Billion INR	-16.54%
2018 Q3	8.1 Billion INR	10.98%
2018 Q2	7.3 Billion INR	19.06%
2018 Q1	6.13 Billion INR	3.6%
2017 Q2	5.39 Billion INR	5.45%
2017 Q1	5.12 Billion INR	6.56%
2017 Q3	5.74 Billion INR	6.35%
2017 FY	20.7 Billion INR	13.72%
2017 Q4	5.91 Billion INR	3.08%
2016 Q2	4.34 Billion INR	12.22%
2016 FY	18.2 Billion INR	12.84%
2016 Q1	3.87 Billion INR	-16.24%
2016 Q3	4.54 Billion INR	4.58%
2016 Q4	4.8 Billion INR	5.74%
2015 Q4	4.62 Billion INR	11.53%
2015 FY	16.13 Billion INR	12.17%
2015 Q2	3.8 Billion INR	6.78%
2015 Q3	4.14 Billion INR	9.01%
2015 Q1	3.56 Billion INR	-9.34%
2014 FY	14.38 Billion INR	9.82%
2014 Q3	3.75 Billion INR	5.12%
2014 Q4	3.92 Billion INR	4.73%
2014 Q2	3.56 Billion INR	13.8%
2014 Q1	3.13 Billion INR	-31.05%
2013 Q3	2.75 Billion INR	-10.58%
2013 FY	13.09 Billion INR	32.86%
2013 Q1	2.7 Billion INR	-8.21%
2013 Q2	3.08 Billion INR	13.88%
2013 Q4	4.54 Billion INR	64.91%
2012 Q2	2.51 Billion INR	5.55%
2012 FY	9.85 Billion INR	15.65%
2012 Q4	2.94 Billion INR	21.7%
2012 Q3	2.42 Billion INR	-3.74%
2012 Q1	2.38 Billion INR	-19.27%
2011 Q4	2.95 Billion INR	41.03%
2011 Q3	2.09 Billion INR	0.0%
2011 FY	8.52 Billion INR	371.89%
2010 FY	-3.13 Billion INR	-163.12%
2009 FY	4.96 Billion INR	82.68%
2008 FY	2.71 Billion INR	63.12%
2007 FY	1.66 Billion INR	3.94%
2006 FY	1.6 Billion INR	89.29%
2005 FY	847.02 Million INR	15.42%
2004 FY	733.89 Million INR	-1.8%
2003 FY	747.32 Million INR	0.0%

Peer Operating Expenses Comparison of Biocon Limited

Name	Operating Expenses	Operating Expenses Difference
Blue Jet Healthcare Limited	531.85 Million INR	-7590.702%
Concord Biotech Limited	1.45 Billion INR	-2702.145%
Dishman Carbogen Amcis Limited	5.14 Billion INR	-694.634%
Jubilant Ingrevia Limited	6.67 Billion INR	-513.238%
Lyka Labs Limited	599.4 Million INR	-6723.911%
Panacea Biotec Limited	1.99 Billion INR	-1949.865%
Piramal Pharma Limited	19.91 Billion INR	-105.398%
SMS Lifesciences India Limited	602.96 Million INR	-6683.622%
Supriya Lifescience Limited	1.08 Billion INR	-3686.789%
Syngene International Limited	5.99 Billion INR	-582.285%
TAKE Solutions Limited	396.91 Million INR	-10205.359%
Zota Health Care Limited	457.83 Million INR	-8834.005%

Global Stocks Search

Biocon Limited (BIOCON.NS)

Operating Expenses Summary of Biocon Limited

Annual Operating Expenses Chart of Biocon Limited (2023 - 2003)

Historical Annual Operating Expenses of Biocon Limited (2023 - 2003)

Peer Operating Expenses Comparison of Biocon Limited